Exhibit 107

Calculation of Filing Fee Table

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

(Form Type)

BRIACELL THERAPEUTICS CORP.

(Exact Name of Registrant As Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type		Security Class Title		Fee Calculation Rule		Amount Registered(1)			Proposed Maximum Offering Price Per Share			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Newly Registered Securities
Fees to Be Paid		Equity		Common Shares		457(c) and (h)		2,693,094	(2)	$	0.79	(3)		2,127,544.26	$	0.00015310	$	326
Fees Previously Paid		-		-		-		-			-			-		-		0
Total Offering Amounts														2,127,544.26	$	-	$	326
Total Fees Previously Paid													$	-		-	$	-
Total Fee Offsets														-		-	$	-
Net Fees Due													$	-		-	$	326

(1)	Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.
(2)	Represents Common Shares reserved for future issuance under the Company’s Omnibus Equity Incentive Plan.
(3)	Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per Common Share on July 28, 2025, as reported on the Nasdaq Capital Market.